SCNI
Scinai Immunotherapeutics
SCNI
SCNI
5 hedge funds and large institutions have $495K invested in Scinai Immunotherapeutics in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Jane Street
New York
|
$391K |
| 2 |
VKH
2
Virtu KCG Holdings
New York
|
$82K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$13K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$6K |
| 5 |
5
Citigroup
New York
|
$3K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $391K | +$391K | +790 | New |
|
|
VKH
2
Virtu KCG Holdings
New York
| $82K | +$82K | +165 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $13K | +$13K | +26 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $6K | +$6K | +13 | New |
|
|
5
Citigroup
New York
| $3K | +$3K | +7 | New |
|